Cargando…
Interferon-γ-induced protein 10 (IP-10) and serum amyloid A (SAA) are excellent biomarkers for the prediction of COVID-19 progression and severity
AIMS: Early diagnosis and appropriate treatment are essential in reducing the morbidity and mortality of COVID-19-infected patients. The current study aimed to measure the levels of serum IP-10 and SAA in positive COVID-19 Egyptian patients to explore their clinical values and significance in discri...
Autores principales: | Haroun, Riham Abdel-Hamid, Osman, Waleed H., Eessa, Asmaa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832132/ https://www.ncbi.nlm.nih.gov/pubmed/33454365 http://dx.doi.org/10.1016/j.lfs.2021.119019 |
Ejemplares similares
-
Evaluation of serum total sialic acid in moderate COVID-19 patients with and without gastrointestinal tract manifestations
por: Haroun, Riham Abdel-Hamid, et al.
Publicado: (2022) -
Prognostic significance of serum miR-18a-5p in severe COVID-19 Egyptian patients
por: Haroun, Riham Abdel-Hamid, et al.
Publicado: (2023) -
Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection
por: Haroun, Riham Abdel-Hamid, et al.
Publicado: (2022) -
Evaluation of an in-clinic Serum Amyloid A (SAA) assay and assessment of the effects of storage on SAA samples
por: Hillström, Anna, et al.
Publicado: (2010) -
High-Density Lipoproteins and Serum Amyloid A (SAA)
por: Webb, Nancy R.
Publicado: (2021)